Control of hyperparathyroidism with the intravenous calcimimetic etelcalcetide in dialysis patients adherent and non-adherent to oral calcimimetics.

Clin Kidney J · 2021 · PMC7986320 · PMID 33777366

Europe PMC DOI

hedged sentence

0.1840

closest p · 3.7× alpha

0.1840

boldest claim

The sentences

did not reach statistical significanceP = 0.184not close (p > 0.1)

The mean PTH value throughout the previous 6 months was slightly higher in non-adherent (761 ± 377 pg/mL) than in adherent patients (579 ± 228 pg/mL), although this difference did not reach statistical significance (P = 0.184).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.